U
CXM

UBS’s CARDIUM THERAPEUTICS INC NEW CXM Stock Holding History

UBS’s Portfolio CXM Stock Details CXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-400
Closed – – 11420
2013
Q4 		$0 Hold
400
– – ﹤0.01% 11237
2013
Q3 		$0 Sell
400
-2,990
-88% -$3.04K ﹤0.01% 11157
2013
Q2 		$5K Buy
+3,390
New +$6.1K ﹤0.01% 9344

UBS's CXM Position: Q1 2014 in Review

UBS sold out of CARDIUM THERAPEUTICS INC NEW (CXM) in Q1 2014, closing a stake of 400 shares.

UBS first reported a position in CXM in Q2 2013 and held it in 3 quarters. The position peaked at $5K in Q2 2013. 0 funds tracked by Wall St. Rank hold CXM as of Q1 2014.

  • UBS reported no remaining CARDIUM THERAPEUTICS INC NEW position as of Q1 2014 after selling out during the quarter.
  • UBS sold 400 CARDIUM THERAPEUTICS INC NEW shares in Q1 2014.
  • UBS first reported a position in CARDIUM THERAPEUTICS INC NEW in Q2 2013 and held it in 3 quarters.
  • UBS's CARDIUM THERAPEUTICS INC NEW position peaked at $5K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held CARDIUM THERAPEUTICS INC NEW as of Q1 2014.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.